A citation-based method for searching scientific literature

M B Toft-Nielsen, M B Damholt, S Madsbad, L M Hilsted, T E Hughes, B K Michelsen, J J Holst. J Clin Endocrinol Metab 2001
Times Cited: 615







List of co-cited articles
980 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
M A Nauck, I Vardarli, C F Deacon, J J Holst, J J Meier. Diabetologia 2011
301
25

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.
S Calanna, M Christensen, J J Holst, B Laferrère, L L Gluud, T Vilsbøll, F K Knop. Diabetologia 2013
145
25

GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.
Kristine Færch, Signe S Torekov, Dorte Vistisen, Nanna B Johansen, Daniel R Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Annelli Sandbæk,[...]. Diabetes 2015
138
24

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
20

The physiology of glucagon-like peptide 1.
Jens Juul Holst. Physiol Rev 2007
19

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.
Elza Muscelli, Andrea Mari, Arturo Casolaro, Stefania Camastra, Giuseppe Seghieri, Amalia Gastaldelli, Jens J Holst, Ele Ferrannini. Diabetes 2008
252
19


Reduced incretin effect in type 2 (non-insulin-dependent) diabetes.
M Nauck, F Stöckmann, R Ebert, W Creutzfeldt. Diabetologia 1986
864
16


Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
M A Nauck, E Homberger, E G Siegel, R C Allen, R P Eaton, R Ebert, W Creutzfeldt. J Clin Endocrinol Metab 1986
563
15



Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Kirsten Vollmer, Jens J Holst, Birgit Baller, Mark Ellrichmann, Michael A Nauck, Wolfgang E Schmidt, Juris J Meier. Diabetes 2008
236
14


Attenuated GLP-1 secretion in obesity: cause or consequence?
L R Ranganath, J M Beety, L M Morgan, J W Wright, R Howland, V Marks. Gut 1996
248
11

Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies.
Salvatore Calanna, Mikkel Christensen, Jens J Holst, Blandine Laferrère, Lise L Gluud, Tina Vilsbøll, Filip K Knop. Diabetes Care 2013
85
12

The biology of incretin hormones.
Daniel J Drucker. Cell Metab 2006
10

Inhibition of gastric inhibitory polypeptide signaling prevents obesity.
Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni,[...]. Nat Med 2002
602
10

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
697
10

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.
A Wettergren, B Schjoldager, P E Mortensen, J Myhre, J Christiansen, J J Holst. Dig Dis Sci 1993
528
9

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
T Vilsbøll, T Krarup, J Sonne, S Madsbad, A Vølund, A G Juul, J J Holst. J Clin Endocrinol Metab 2003
363
9

Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes.
Jens J Holst, Filip K Knop, Tina Vilsbøll, Thure Krarup, Sten Madsbad. Diabetes Care 2011
169
9

Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT.
Marjan Alssema, Josina M Rijkelijkhuizen, Jens J Holst, Tom Teerlink, Peter G Scheffer, Elisabeth M W Eekhoff, Amalia Gastaldelli, Andrea Mari, Leen M't Hart, Giel Nijpels,[...]. Eur J Endocrinol 2013
38
23


Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
9

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
9

Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
8

Impaired regulation of the incretin effect in patients with type 2 diabetes.
Jonatan I Bagger, Filip K Knop, Asger Lund, Henrik Vestergaard, Jens J Holst, Tina Vilsbøll. J Clin Endocrinol Metab 2011
132
8

Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes.
Chee W Chia, Olga D Carlson, Wook Kim, Yu-Kyong Shin, Cornelia P Charles, Hee Seung Kim, Denise L Melvin, Josephine M Egan. Diabetes 2009
105
8



GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine.
Kristine Mortensen, Louise Lundby Christensen, Jens Juul Holst, Cathrine Orskov. Regul Pept 2003
238
8

Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.
Hyeung-Jin Jang, Zaza Kokrashvili, Michael J Theodorakis, Olga D Carlson, Byung-Joon Kim, Jie Zhou, Hyeon Ho Kim, Xiangru Xu, Sic L Chan, Magdalena Juhaszova,[...]. Proc Natl Acad Sci U S A 2007
654
8

Pharmacology, physiology, and mechanisms of incretin hormone action.
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
731
8


Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
C Orskov, L Rabenhøj, A Wettergren, H Kofod, J J Holst. Diabetes 1994
707
8


Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
E Rask, T Olsson, S Söderberg, J j Holst Jj, A Tura, G Pacini, B Ahrén. Metabolism 2004
72
11



Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.
Brian Finan, Tao Ma, Nickki Ottaway, Timo D Müller, Kirk M Habegger, Kristy M Heppner, Henriette Kirchner, Jenna Holland, Jazzminn Hembree, Christine Raver,[...]. Sci Transl Med 2013
276
8

Incretin hormones: Their role in health and disease.
Michael A Nauck, Juris J Meier. Diabetes Obes Metab 2018
161
8

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
A Flint, A Raben, A Astrup, J J Holst. J Clin Invest 1998
913
7

Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.
E Rask, T Olsson, S Söderberg, O Johnson, J Seckl, J J Holst, B Ahrén. Diabetes Care 2001
164
7

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man.
R Eissele, R Göke, S Willemer, H P Harthus, H Vermeer, R Arnold, B Göke. Eur J Clin Invest 1992
441
7


The incretin concept today.
W Creutzfeldt. Diabetologia 1979
649
7

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.